Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by Barton Russell. Insider active across 1 company, notably Acumen Pharmaceuticals, Inc.. Aggregated, 10 reports have been logged. Breakdown: 0 buy · 6 sells. Total volume traded: €44k. History available since 17 January 2023. The latest transaction was disclosed on 21 January 2026 (Cession). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations
Barton Russell is Chief Operating Officer at Acumen Pharmaceuticals, Inc. (XNAS). He has 10 filings in total, and across the 10 sampled filings from 2023-01-18 to 2026-01-23, the transactions are sells for a total of EUR 43928, with the largest filings at EUR 13853.54055545913 on 2025-01-07, EUR 9696.31460639862 on 2024-01-19, and EUR 6691.689272519557 on 2026-01-07.